Evidence map›Paper›PMID 30911570›Full record

ArticleAnnals of clinical and translational neurology2019

Cognitive deficits in acute mild ischemic stroke and TIA and effects of rt-PA.

David Rosenbaum Halevi, Andrew W Bursaw, Rahul R Karamchandani, Susan E Alderman, Joshua I Breier, Farhaan S Vahidy, James K Aden, Chunyan Cai, Xu Zhang, Sean I Savitz

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

David Rosenbaum HaleviDepartment of Neurology and Institute for Stroke and Cerebrovascular Disease UTHealth Houston Texas.
Andrew W BursawUS Air Force Academy Colorado Springs Colorado.
Rahul R KaramchandaniCarolinas Neuroscience Institute Raleigh North Carolina.
Susan E AldermanCizik School of Nursing UTHealth Houston Texas.
Joshua I BreierCenter for Clinical Neurosciences UTHealth Houston Texas.
Farhaan S VahidyDepartment of Neurology and Institute for Stroke and Cerebrovascular Disease UTHealth Houston Texas.
James K AdenInstitute for Surgical Research Joint Base San Antonio San Antonio Texas.
Chunyan CaiDepartment of Neurology and Institute for Stroke and Cerebrovascular Disease UTHealth Houston Texas.
Xu ZhangDepartment of Neurology and Institute for Stroke and Cerebrovascular Disease UTHealth Houston Texas.
Sean I SavitzDepartment of Neurology and Institute for Stroke and Cerebrovascular Disease UTHealth Houston Texas.
The University of Texas Health Science Center at Houston · USJoint Base San Antonio · USNeurosciences Institute · USThe University of Texas Health Science Center · USUnited States Air Force Academy · US

Funding

Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
NCATS NIH HHS UL1 TR000371
6 · The paper itself

Abstract

Introduction: It is unknown if treatment with rt-PA in mild acute ischemic stroke (MIS) is associated with improvement in long term cognition. Methods: Forty-five patients with suspected acute mild stroke or transient ischemic attacks with NIHSS ≤6 were enrolled in a prospective cohort. Cognitive testing was performed within 24 h of symptom onset. Follow-up assessment was performed at Day 90 on 25 patients. Prestroke baseline cognition was based on age, years of education (YrE), history of cognitive impairment, and the Fazekas score. Results: Eighty-five percent patients with suspected MIS or TIA showed cognitive abnormalities within 24 h of onset. There was no significant difference in age, sex, Fazekas score, or YrE between rt-PA versus No-rt-PA groups ( Conclusion: Suspected MIS and TIA patients have cognitive impairment within 24 h of onset. rt-PA administration might be associated with improvement on some cognitive tests at 90 days.

Indexed as

AdultAgedAged, 80 and overCognitive DysfunctionCohort StudiesFemaleHumansIschemic Attack, TransientMaleMiddle AgedProspective StudiesStrokeTime FactorsTissue Plasminogen ActivatorTissue Plasminogen Activator

Identifiers

PMID30911570
PMCPMC6414481
OpenAlexW2914886218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.